Aim: The aim of the paper is to evaluate the appearance of the new early ischemic lesions in the brain after carotid angioplasty and stenting on diffusion-weighted magnetic resonance imaging, and their relationship with clinical and procedural factors.
Methods: Carotid artery stenting (CAS) procedures performed by a single interventional cardiologist in years November 2006 to January 2013 were evaluated retrospectively. In total, 227 procedures for 211 patients (mean age 69.8 ± 8.5 years) were performed, from which 171 (75.3%) for male and 56 (24.7%) for female patients. Seventy-two (34.1%) patients had symptomatic stenosis of carotid artery. The following protection systems to avoid the distal microembolism were used during the CAS: (1) Filters: FilterWire EZ (Boston Scientific Corporation); Emboshield NAV (Abbott Vascular); SpideRX (EV3); Defender (Medtronic); FiberNet Filter (Invatec-Medtronic); (2) Occlusion MoMa Baloon System (Invatec-Medtronic). Acute ischemic damages of the brain before and after CAS procedure were diagnosed using magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) sequences. Sixty-five (30.8%) patients underwent MRI test. Exact and asymptomatic χ2 criteria were applied for testing the hypothesis of inter-dependency of the symptoms.
Results: Forty-six (70.8%) patients had new ischemic foci in the brain on MRI DWI after CAS procedures. Among those patients, focal damage of the brain was diagnosed in 36 (78.3%) cases; linear damage of the brain - in 9 (19.6%) patients; ipsilateral damage of the brain - in 37 (80.4%) patients; bilateral damage of the brain - in 16 (34.8%) patients, 38 (82.6%) patients were diagnosed with forebrain damage; 4 (8.7%) patients were diagnosed with damage of brainstem; 5 (10.9%) patients were diagnosed with cerebellum damage. Clinical symptoms of brain damage were diagnosed only for 2 (4.3%) patients. Focal damage of the brain was significantly less frequent only for aortic arch type 1, if compared with aortic arch type 2 and 3: 64.3%, 93.3% and 100.0%, respectively (p < 0.05). Focal damage of the brain occurred least in patients (28.6%) with Emboshield NAV protection type, if compared to other types of protection (71.4-100.0%). Linear >10mmbrain damage was less frequent when using FilterWire EZ, Emboshield NAV and SpideRX protection type. Ipsilateral ischemic brain damage also occurred less frequent when using Emboshield NAV protection type; bilateral damage occurred less frequent when using FilterWire EZ, Emboshield NAV and SpideRX protection type. Ischemic forebrain damage was also diagnosed less often in patients for whom protection type FilterWire EZ and Emboshield NAV was applied.
Conclusions: Most frequent findings by MRI after CAS procedures were focal, ipsilateral and forebrain damage (about 80%), but less than 5% patients had clinical symptoms. In the case of aorta arch type 1 focal ischemic damage of the brain was significantly less frequent, then in aortic arch type 2 and 3. The localization and extent of brain damage was associated with the type of protection systems that have been used.
 Mead GE, Shingler H, Farrell A, O’Neill PA, McCollum CN. Carotid disease in acute stroke. Age Ageing 1998; 27:677-682.
 Malloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis. Stroke 1999; 30:1440-1443.
 CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet 2001; 357:1729-1737.
 Yadav JS, Whole MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid artery stenting versus endarterectomy in high risk patients. N Engl J Med 2004; 351:1493-1501.
 Henry M, Polydorou A, Klonaris C, Henry I, Polydorou AD, Hugel M. Carotid angioplasty and stenting under protection. State of the art. Minerva Cardioangiol 2007; 55:19-56.
 CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 2005; 42:213-219.
 Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R et al, for the ARCHeR Trial Collaborators.Protected carotid stenting in high-risk patients: THE ARCHeR results. J Vasc Surg 2006; 44:258-269.
 Kastrup A, Schulz J, Raygrotzki S, Groschel K, Ernemann U. Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients. J Vasc Surg 2004; 40:945-951.
 Hammer FD, Lacroix V, Duprez T, Grandin C, Verhelst R, Peeters A et al. Cerebral microembolization after protected carotid artery stenting in surgical high-risk patients: Results of a 2-year prospective study. J Vasc Surg 2005; 42:847-853.
 Setacci C, Chisci E, de Donato G, Setacci F, Sirignano P, Galzerano G. Carotid artery stenting in a single center: are six years of experience enough to achieve the standard of care? Eur J Vasc Endovasc Surg 2007; 34:655-662.
 Sadek M, Hynecek RL, Sambol EB, Ur-Rehman H, Kent KC, Faries PL. Carotid angioplasty and stenting success relies on appropriate patient selection. J Vasc Surg 2008; 47:946-951.
 Mas JL, Chatellier G, Beyssen B et al. EVA-3S Investicators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355:1660-1671.
 GrayWA, Yadav JS, Verta P, Scicli A, Fairman R,WholeyM et al. The capture registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 2007; 69:341-348.
 Hobson RW 2nd, Howard VJ, Roubin GS et al; CREST.Credentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. J Vasc Surg 2004; 40:952-957.
 Sacco RL, Adams R, Alberts G, Alberts MJ, Benavente O, Furie K et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: cosponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006; 113:409-449.
 Balzer JO. How to introduce carotid angioplasty without compromising patient safety? Eur J Vasc Endovasc Surg 2008; 36:138-144.
 Rothwell PM, Slattery J, Warlow CP. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systemic review. BMJ 1997; 315:1571-1577.
 Tu JV, Wang H, Bowyer B, Green L, Fang J, Kucey D et al.
Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario Carotid Endarterectomy Registry. Stroke 2003; 34:2568-2573.
 Halm EA, Hannan EL, Rojas M et al. Clinical and operative predictors of outcomes of carotid endarterectomy.J Vasc Surg 2005; 42:420-428.
 Jaeger HJ, Mathias KD, Drescher R et al. Diffusionweighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain. Am J Neuroradiol 2001; 22:1251-1259.
 Cosottini M, Michelassi MC, Puglioli M et al. Silent cerebral ischemia detected with diffusion-weighted imaging in patients treated with protected and unprotected carotid artery stenting. Stroke 2005; 36:2389-2393.
 Pinero P, Gonzalez A, Mayol A et al. Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study. Am J Neuroradiol 2006; 27:1338-1345.
 Faraglia V, Palombo G, Stella N et al. Cerebral embolization in patients undergoing protected carotid-artery stenting and carotid surgery. J Cardiovasc Surg (Torino) 2007; 48:683-688.
 Barbato JE, Dillavou E, Horowitz MB, Jovin TG, Kanal E, David S, Makaroun MS. A randomized trial of carotid stenting with and without cerebral protection. J Vasc Surg 2008; 47:760-765.
 Taha MM, Maeda M, Sakaida H et al. Cerebral ischemic lesions detected with diffusion-weighted magnetic resonance imaging after carotid artery stenting: comparison of several anti-embolic protection devices. Neurol Med Shir (Tokyo) 2009; 49:386-393.
 Bonati LH, Jongen LM, Haller S et al. New ischemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol 2010; 9:353-362.
 Akbulut B, Oc B, OcMet al. Diffusion-weightedmagnetic resonance imaging: comparison of outcome in carotid artery stenosis treatment with different approaches. Anatol J Clin Investig 2009; 3:4-9.
 Linfante I, Andreone V, Akkawi N, Wakhloo AK. Internal carotid artery stenting in patients over 80 years of age: single-center experience and review of the literature.J Neuroimaging 2009; 19:158-163.
 Meyer SA, Gandhi CD, Johnson DM, Winn HR, Patel AB.Outcomes of carotid artery stenting in high-risk patients with carotid artery stenosis: a single neurovascular center retrospective review of 101 consecutive patients. Neurosurgery 2010; 66:448-453; discussion 453-454.
 Rosenkranz M, Thomalla G, Havemeister S, Wittkugel O, Cheng B, Krützelmann A et al. Older age and greater carotid intima-media thickness predict ischemic events associated with carotid-artery stenting. Cerebrovasc Dis 2010; 30:567-572.
 Giannopoulos S, Katsanos AH, Vasdekis SN, Boviatsis E, Voumvourakis KI, Tsivgoulis G. Age and gender disparities in the risk of carotid revascularization procedures.Neurol Sci 2013; doi:10.1007/s10072-013-1453-2.
 Reichmann BL, van Lammeren GW, Moll FL, de Borst GJ.Is age of 80 years a threshold for carotid revascularization? Curr Cardiol Rev 2011; 7:15-21.
 Dumont TM, Mokin M, Wach MM, Drummond PS, Siddiqui AH, Levy EI, Hopkins LN. Understanding risk factors for perioperative ischemic events with carotid stenting: is patient age over 80 years or is unfavorable arch anatomy to blame? J Neurointerv Surg 2013; doi:10.1136/neurintsurg-2013-010721.
 Sakamoto S, Kiura Y, Kajihara Y, Shibukawa M, Okazaki T, Matsushige T et al. Carotid artery stenting using the proximal or dual protection method for near occlusion of the cervical internal carotid artery. Neurosurg Rev 2013; doi:10.1007/s10143-013-0481-y.
 Bijuklic K, Wandler A, Varnakov Y, Tuebler T, Schofer J.Risk factors for cerebral embolization after carotid artery stenting with embolic protection: a diffusion-weighted magnetic resonance imaging study in 837 consecutive patients. Circ Cardiovasc Interv 2013; 6:311-316.
 White CJ, Ramee SR, Collins TJ, Jenkins JS, Reilly JP, Patel RA. Carotid artery stenting: Patient, lesion, and procedural characteristics that increase procedural complications.Catheter Cardiovasc Interv 2013; doi: 10.1002/ccd.24984.
 Mathias K. Carotid artery stenting with filters. J Cardiovasc Surg (Torino) 2013; 54:33-39.
 Kwon SM, Cheong JH, Lee SK, Park DW, Kim JM, Kim CH.Risk factors for developing large emboli following carotid artery stenting. J Korean Neurosurg Soc 2013; 53:155-160.
 Bouziane Z, Nourissat G, Duprey A, Albertini JN, Favre JP, Barral X. Carotid artery surgery: high-risk patients or high-risk centers? Ann Vasc Surg 2012; 26:790-796.
 Mazzaccaro D, Occhiuto MT, Stegher S, Malacrida G, Caldana M, Tealdi DG, Nano G. Long-term results of carotid artery stenting in patients 80 years and older. Perspect Vasc Surg Endovasc Ther 2012; 24:49-54.
 Hoke M, Ljubuncic E, Steinwender C, Huber K, Minar E, Koppensteiner R et al. A validated risk score to predict outcomes after carotid stenting. Circ Cardiovasc Interv 2012; 5:841-849.
 Protack CD, Bakken AM, Xu J, Saad WA, Lumsden AB, Davies MG. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization. J Vasc Surg 2009; 49:1172-1180.
 Trani C, Burzotta F, Coroleu SF. Transradial carotid artery stenting with proximal embolic protection. Catheter Cardiovasc Interv 2009; 74:267-272.